APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor VIIa

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Coagulation Factor VIIa Industry Growth and Trends Forecast to 2032

22 December 202578 pages

Choose your research edition.

Industry ResearchCoagulation Factor VIIa Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor VIIa Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Coagulation Factor VIIa Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor VIIa Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor VIIa Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Coagulation Factor VIIa market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Coagulation Factor VIIa is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Coagulation Factor VIIa is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coagulation Factor VIIa is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coagulation Factor VIIa include Novo Nordisk, LFB SA HEMA Biologics, GENERIUM and AryoGen Pharmed, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Coagulation Factor VIIa market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Coagulation Factor VIIa market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Coagulation Factor VIIa market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Coagulation Factor VIIa.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Coagulation Factor VIIa market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Coagulation Factor VIIa Market by Company

Novo Nordisk

LFB SA HEMA Biologics

GENERIUM

AryoGen Pharmed

Coagulation Factor VIIa Segment by Type

Prefilled Syringe

Vial

Coagulation Factor VIIa Segment by Application

Congenital Hemophilia

Acquired Hemophilia

Other

Coagulation Factor VIIa Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor VIIa market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor VIIa and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor VIIa.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coagulation Factor VIIa manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Coagulation Factor VIIa in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Prefilled Syringe Table 2. Major Company of Vial Table 3. Global Coagulation Factor VIIa Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 5. Global Coagulation Factor VIIa Sales Market Share in Volume by Type (2021-2026) Table 6. Global Coagulation Factor VIIa Sales by Type (2021-2026) & (US$ Million) Table 7. Global Coagulation Factor VIIa Sales Market Share in Value by Type (2021-2026) Table 8. Global Coagulation Factor VIIa Price by Type (2021-2026) & (US$/kg) Table 9. Global Coagulation Factor VIIa Sales by Type (2027-2032) & (tons) Table 10. Global Coagulation Factor VIIa Sales Market Share in Volume by Type (2027-2032) Table 11. Global Coagulation Factor VIIa Sales by Type (2027-2032) & (US$ Million) Table 12. Global Coagulation Factor VIIa Sales Market Share in Value by Type (2027-2032) Table 13. Global Coagulation Factor VIIa Price by Type (2027-2032) & (US$/kg) Table 14. North America Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 15. North America Coagulation Factor VIIa Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 17. Europe Coagulation Factor VIIa Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 19. Asia-Pacific Coagulation Factor VIIa Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 21. Latin America Coagulation Factor VIIa Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Coagulation Factor VIIa Sales by Type (2021-2026) & (tons) Table 23. Middle East and Africa Coagulation Factor VIIa Sales by Type (2021-2026) & (US$ Million) Table 24. Coagulation Factor VIIa Industry Trends Table 25. Coagulation Factor VIIa Industry Drivers Table 26. Coagulation Factor VIIa Industry Opportunities and Challenges Table 27. Coagulation Factor VIIa Industry Restraints Table 28. Global Coagulation Factor VIIa Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Coagulation Factor VIIa Revenue Market Share by Company (2021-2026) Table 30. Global Coagulation Factor VIIa Sales by Company (2021-2026) & (tons) Table 31. Global Coagulation Factor VIIa Sales Share by Company (2021-2026) Table 32. Global Coagulation Factor VIIa Market Price by Company (2021-2026) & (US$/kg) Table 33. Global Coagulation Factor VIIa Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Coagulation Factor VIIa Major Company Production Sites and Headquarters Table 35. Global Coagulation Factor VIIa Company, Product Type & Application Table 36. Global Coagulation Factor VIIa Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Coagulation Factor VIIa by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Coagulation Factor VIIa Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Coagulation Factor VIIa Sales by Region (2021-2026) & (tons) Table 41. Global Coagulation Factor VIIa Sales Market Share in Volume by Region (2021-2026) Table 42. Global Coagulation Factor VIIa Sales by Region (2021-2026) & (US$ Million) Table 43. Global Coagulation Factor VIIa Sales Market Share in Value by Region (2021-2026) Table 44. Global Coagulation Factor VIIa Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 45. Global Coagulation Factor VIIa Sales by Region (2027-2032) & (tons) Table 46. Global Coagulation Factor VIIa Sales Market Share in Volume by Region (2027-2032) Table 47. Global Coagulation Factor VIIa Sales by Region (2027-2032) & (US$ Million) Table 48. Global Coagulation Factor VIIa Sales Market Share in Value by Region (2027-2032) Table 49. Global Coagulation Factor VIIa Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 50. Global Coagulation Factor VIIa Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 52. Global Coagulation Factor VIIa Sales Market Share in Volume by Application (2021-2026) Table 53. Global Coagulation Factor VIIa Sales by Application (2021-2026) & (US$ Million) Table 54. Global Coagulation Factor VIIa Sales Market Share in Value by Application (2021-2026) Table 55. Global Coagulation Factor VIIa Price by Application (2021-2026) & (US$/kg) Table 56. Global Coagulation Factor VIIa Sales by Application (2027-2032) & (tons) Table 57. Global Coagulation Factor VIIa Sales Market Share in Volume by Application (2027-2032) Table 58. Global Coagulation Factor VIIa Sales by Application (2027-2032) & (US$ Million) Table 59. Global Coagulation Factor VIIa Sales Market Share in Value by Application (2027-2032) Table 60. Global Coagulation Factor VIIa Price by Application (2027-2032) & (US$/kg) Table 61. North America Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 62. North America Coagulation Factor VIIa Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 64. Europe Coagulation Factor VIIa Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 66. Asia-Pacific Coagulation Factor VIIa Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 68. Latin America Coagulation Factor VIIa Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Coagulation Factor VIIa Sales by Application (2021-2026) & (tons) Table 70. Middle East and Africa Coagulation Factor VIIa Sales by Application (2021-2026) & (US$ Million) Table 71. Novo Nordisk Company Information Table 72. Novo Nordisk Business Overview Table 73. Novo Nordisk Coagulation Factor VIIa Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Novo Nordisk Coagulation Factor VIIa Product Portfolio Table 75. Novo Nordisk Recent Development Table 76. LFB SA HEMA Biologics Company Information Table 77. LFB SA HEMA Biologics Business Overview Table 78. LFB SA HEMA Biologics Coagulation Factor VIIa Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. LFB SA HEMA Biologics Coagulation Factor VIIa Product Portfolio Table 80. LFB SA HEMA Biologics Recent Development Table 81. GENERIUM Company Information Table 82. GENERIUM Business Overview Table 83. GENERIUM Coagulation Factor VIIa Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. GENERIUM Coagulation Factor VIIa Product Portfolio Table 85. GENERIUM Recent Development Table 86. AryoGen Pharmed Company Information Table 87. AryoGen Pharmed Business Overview Table 88. AryoGen Pharmed Coagulation Factor VIIa Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. AryoGen Pharmed Coagulation Factor VIIa Product Portfolio Table 90. AryoGen Pharmed Recent Development Table 91. North America Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 92. North America Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 93. North America Coagulation Factor VIIa Sales Market Share by Country (2021-2026) Table 94. North America Coagulation Factor VIIa Sales Forecast by Country (2027-2032) & (tons) Table 95. North America Coagulation Factor VIIa Sales Market Share Forecast by Country (2027-2032) Table 96. North America Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Coagulation Factor VIIa Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Coagulation Factor VIIa Market Share by Country (2021-2026) Table 99. North America Coagulation Factor VIIa Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Coagulation Factor VIIa Market Share Forecast by Country (2027-2032) Table 101. Europe Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 102. Europe Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 103. Europe Coagulation Factor VIIa Sales Market Share by Country (2021-2026) Table 104. Europe Coagulation Factor VIIa Sales Forecast by Country (2027-2032) & (tons) Table 105. Europe Coagulation Factor VIIa Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Coagulation Factor VIIa Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Coagulation Factor VIIa Market Share by Country (2021-2026) Table 109. Europe Coagulation Factor VIIa Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Coagulation Factor VIIa Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 113. Asia-Pacific Coagulation Factor VIIa Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Coagulation Factor VIIa Sales Forecast by Country (2027-2032) & (tons) Table 115. Asia-Pacific Coagulation Factor VIIa Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Coagulation Factor VIIa Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Coagulation Factor VIIa Market Share by Country (2021-2026) Table 119. Asia-Pacific Coagulation Factor VIIa Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Coagulation Factor VIIa Market Share Forecast by Country (2027-2032) Table 121. Latin America Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 122. Latin America Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 123. Latin America Coagulation Factor VIIa Sales Market Share by Country (2021-2026) Table 124. Latin America Coagulation Factor VIIa Sales Forecast by Country (2027-2032) & (tons) Table 125. Latin America Coagulation Factor VIIa Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Coagulation Factor VIIa Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Coagulation Factor VIIa Market Share by Country (2021-2026) Table 129. Latin America Coagulation Factor VIIa Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Coagulation Factor VIIa Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 133. Middle East and Africa Coagulation Factor VIIa Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Coagulation Factor VIIa Sales Forecast by Country (2027-2032) & (tons) Table 135. Middle East and Africa Coagulation Factor VIIa Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Coagulation Factor VIIa Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Coagulation Factor VIIa Market Share by Country (2021-2026) Table 139. Middle East and Africa Coagulation Factor VIIa Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Coagulation Factor VIIa Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Coagulation Factor VIIa Distributors List Table 144. Coagulation Factor VIIa Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Coagulation Factor VIIa Image Figure 2. Global Coagulation Factor VIIa Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor VIIa Market Size (2021-2032) & (US$ Million) Figure 4. Global Coagulation Factor VIIa Sales (2021-2032) & (tons) Figure 5. Prefilled Syringe Image Figure 6. Global Prefilled Syringe Sales YoY Growth (2021-2032) & (tons) Figure 7. Vial Image Figure 8. Global Vial Sales YoY Growth (2021-2032) & (tons) Figure 9. Global Coagulation Factor VIIa Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Coagulation Factor VIIa Market Share by Type 2025 VS 2032 Figure 11. North America Coagulation Factor VIIa Sales Market Share in Volume by Type in 2025 Figure 12. North America Coagulation Factor VIIa Sales Market Share in Value by Type in 2025 Figure 13. Europe Coagulation Factor VIIa Sales Market Share in Volume by Type in 2025 Figure 14. Europe Coagulation Factor VIIa Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Coagulation Factor VIIa Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Coagulation Factor VIIa Sales Market Share in Value by Type in 2025 Figure 17. Latin America Coagulation Factor VIIa Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Coagulation Factor VIIa Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Coagulation Factor VIIa Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Coagulation Factor VIIa Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Coagulation Factor VIIa Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Congenital Hemophilia Image Figure 24. Global Congenital Hemophilia Sales YoY Growth (2021-2032) & (tons) Figure 25. Acquired Hemophilia Image Figure 26. Global Acquired Hemophilia Sales YoY Growth (2021-2032) & (tons) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (tons) Figure 29. Global Coagulation Factor VIIa Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Coagulation Factor VIIa Market Share by Application 2025 VS 2032 Figure 31. North America Coagulation Factor VIIa Sales Market Share in Volume by Application in 2025 Figure 32. North America Coagulation Factor VIIa Sales Market Share in Value by Application in 2025 Figure 33. Europe Coagulation Factor VIIa Sales Market Share in Volume by Application in 2025 Figure 34. Europe Coagulation Factor VIIa Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Coagulation Factor VIIa Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Coagulation Factor VIIa Sales Market Share in Value by Application in 2025 Figure 37. Latin America Coagulation Factor VIIa Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Coagulation Factor VIIa Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Coagulation Factor VIIa Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Coagulation Factor VIIa Sales Market Share in Value by Application in 2025 Figure 41. North America Coagulation Factor VIIa Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 42. North America Coagulation Factor VIIa Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Coagulation Factor VIIa Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Coagulation Factor VIIa Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. Europe Coagulation Factor VIIa Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Coagulation Factor VIIa Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Coagulation Factor VIIa Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Asia-Pacific Coagulation Factor VIIa Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Coagulation Factor VIIa Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Coagulation Factor VIIa Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Latin America Coagulation Factor VIIa Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Coagulation Factor VIIa Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Coagulation Factor VIIa Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Middle East and Africa Coagulation Factor VIIa Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Coagulation Factor VIIa Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Coagulation Factor VIIa Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Coagulation Factor VIIa Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Prefilled Syringe
  • Vial
Applications
  • Congenital Hemophilia
  • Acquired Hemophilia
  • Other
Companies covered
  • Novo Nordisk
  • LFB SA HEMA Biologics
  • GENERIUM
  • AryoGen Pharmed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coagulation Factor VIIa Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Coagulation Factor VIIa Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Coagulation Factor VIIa Market by Type
  6. 1.3.1 Prefilled Syringe
  7. 1.3.2 Vial
  8. 1.4 Global Coagulation Factor VIIa Market Size by Type
  9. 1.4.1 Global Coagulation Factor VIIa Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Coagulation Factor VIIa Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Coagulation Factor VIIa Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Coagulation Factor VIIa Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Coagulation Factor VIIa Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Coagulation Factor VIIa Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Coagulation Factor VIIa Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Coagulation Factor VIIa Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Coagulation Factor VIIa Industry Trends
  2. 2.2 Coagulation Factor VIIa Industry Drivers
  3. 2.3 Coagulation Factor VIIa Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor VIIa Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Coagulation Factor VIIa Revenue (2021-2026)
  2. 3.2 Global Top Players by Coagulation Factor VIIa Sales (2021-2026)
  3. 3.3 Global Top Players by Coagulation Factor VIIa Price (2021-2026)
  4. 3.4 Global Coagulation Factor VIIa Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coagulation Factor VIIa Major Company Production Sites & Headquarters
  6. 3.6 Global Coagulation Factor VIIa Company, Product Type & Application
  7. 3.7 Global Coagulation Factor VIIa Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coagulation Factor VIIa Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coagulation Factor VIIa Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coagulation Factor VIIa Tier 1, Tier 2, and Tier 3
4 Coagulation Factor VIIa Regional Status and Outlook
  1. 4.1 Global Coagulation Factor VIIa Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Coagulation Factor VIIa Historic Market Size by Region
  3. 4.2.1 Global Coagulation Factor VIIa Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Coagulation Factor VIIa Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Coagulation Factor VIIa Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Coagulation Factor VIIa Forecasted Market Size by Region
  7. 4.3.1 Global Coagulation Factor VIIa Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Coagulation Factor VIIa Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Coagulation Factor VIIa Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Coagulation Factor VIIa by Application
  1. 5.1 Coagulation Factor VIIa Market by Application
  2. 5.1.1 Congenital Hemophilia
  3. 5.1.2 Acquired Hemophilia
  4. 5.1.3 Other
  5. 5.2 Global Coagulation Factor VIIa Market Size by Application
  6. 5.2.1 Global Coagulation Factor VIIa Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Coagulation Factor VIIa Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Coagulation Factor VIIa Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Coagulation Factor VIIa Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Coagulation Factor VIIa Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Coagulation Factor VIIa Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Coagulation Factor VIIa Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Coagulation Factor VIIa Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novo Nordisk
  2. 6.1.1 Novo Nordisk Company Information
  3. 6.1.2 Novo Nordisk Business Overview
  4. 6.1.3 Novo Nordisk Coagulation Factor VIIa Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novo Nordisk Coagulation Factor VIIa Product Portfolio
  6. 6.1.5 Novo Nordisk Recent Developments
  7. 6.2 LFB SA HEMA Biologics
  8. 6.2.1 LFB SA HEMA Biologics Company Information
  9. 6.2.2 LFB SA HEMA Biologics Business Overview
  10. 6.2.3 LFB SA HEMA Biologics Coagulation Factor VIIa Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 LFB SA HEMA Biologics Coagulation Factor VIIa Product Portfolio
  12. 6.2.5 LFB SA HEMA Biologics Recent Developments
  13. 6.3 GENERIUM
  14. 6.3.1 GENERIUM Company Information
  15. 6.3.2 GENERIUM Business Overview
  16. 6.3.3 GENERIUM Coagulation Factor VIIa Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GENERIUM Coagulation Factor VIIa Product Portfolio
  18. 6.3.5 GENERIUM Recent Developments
  19. 6.4 AryoGen Pharmed
  20. 6.4.1 AryoGen Pharmed Company Information
  21. 6.4.2 AryoGen Pharmed Business Overview
  22. 6.4.3 AryoGen Pharmed Coagulation Factor VIIa Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AryoGen Pharmed Coagulation Factor VIIa Product Portfolio
  24. 6.4.5 AryoGen Pharmed Recent Developments
7 North America by Country
  1. 7.1 North America Coagulation Factor VIIa Sales by Country
  2. 7.1.1 North America Coagulation Factor VIIa Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Coagulation Factor VIIa Sales by Country (2021-2026)
  4. 7.1.3 North America Coagulation Factor VIIa Sales Forecast by Country (2027-2032)
  5. 7.2 North America Coagulation Factor VIIa Market Size by Country
  6. 7.2.1 North America Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Coagulation Factor VIIa Market Size by Country (2021-2026)
  8. 7.2.3 North America Coagulation Factor VIIa Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Coagulation Factor VIIa Sales by Country
  2. 8.1.1 Europe Coagulation Factor VIIa Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Coagulation Factor VIIa Sales by Country (2021-2026)
  4. 8.1.3 Europe Coagulation Factor VIIa Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Coagulation Factor VIIa Market Size by Country
  6. 8.2.1 Europe Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Coagulation Factor VIIa Market Size by Country (2021-2026)
  8. 8.2.3 Europe Coagulation Factor VIIa Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Coagulation Factor VIIa Sales by Country
  2. 9.1.1 Asia-Pacific Coagulation Factor VIIa Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Coagulation Factor VIIa Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Coagulation Factor VIIa Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Coagulation Factor VIIa Market Size by Country
  6. 9.2.1 Asia-Pacific Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Coagulation Factor VIIa Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Coagulation Factor VIIa Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Coagulation Factor VIIa Sales by Country
  2. 10.1.1 South America Coagulation Factor VIIa Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Coagulation Factor VIIa Sales by Country (2021-2026)
  4. 10.1.3 South America Coagulation Factor VIIa Sales Forecast by Country (2027-2032)
  5. 10.2 South America Coagulation Factor VIIa Market Size by Country
  6. 10.2.1 South America Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Coagulation Factor VIIa Market Size by Country (2021-2026)
  8. 10.2.3 South America Coagulation Factor VIIa Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Coagulation Factor VIIa Sales by Country
  2. 11.1.1 Middle East and Africa Coagulation Factor VIIa Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Coagulation Factor VIIa Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Coagulation Factor VIIa Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Coagulation Factor VIIa Market Size by Country
  6. 11.2.1 Middle East and Africa Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Coagulation Factor VIIa Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Coagulation Factor VIIa Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Coagulation Factor VIIa Value Chain Analysis
  2. 12.1.1 Coagulation Factor VIIa Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Coagulation Factor VIIa Production Mode & Process
  7. 12.2 Coagulation Factor VIIa Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Coagulation Factor VIIa Distributors
  10. 12.2.3 Coagulation Factor VIIa Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst